Scribe Therapeutics (SCTX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $20.08, -3.09% vs the prior close of $20.72.
- Volume 201.39K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SCTX slides 3.1% to $20.08. Closed at $20.08, -3.09% vs the prior close of $20.72. Day range $19.72–$21.00, opened at $20.86.
SCTX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — SCTX slides 3.1% to $20.08
- Closed at $20.08, -3.09% vs the prior close of $20.72. Day range $19.72–$21.00, opened at $20.86.
- Volume was 201.39K shares, 0.5x its 50-day average of 375.67K — lighter than usual.
- Price is -21.7% vs its 50-day average ($25.64).
- 52-week range $13.50–$39.60; today's close sits at 25% of that range, 49.3% below the 52-week high.
Oct 15, 2026 — SCTX ends flat (-0.2%) to $20.72
- Closed at $20.72, -0.24% vs the prior close of $20.77. Day range $19.73–$21.95, opened at $20.79.
- Volume was 180.90K shares, 0.5x its 50-day average of 377.39K — lighter than usual.
- Price is -19.5% vs its 50-day average ($25.75).
- 52-week range $13.50–$39.60; today's close sits at 28% of that range, 47.7% below the 52-week high.
Oct 14, 2026 — SCTX jumps 8.6% to $20.77
- Closed at $20.77, +8.63% vs the prior close of $19.12. Day range $18.81–$21.99, opened at $18.81.
- Volume was 391.30K shares, 1.1x its 50-day average of 372.56K.
- Price is -19.5% vs its 50-day average ($25.81).
- 52-week range $13.50–$39.60; today's close sits at 28% of that range, 47.6% below the 52-week high.
Oct 13, 2026 — SCTX slides 7.5% to $19.12
- Closed at $19.12, -7.50% vs the prior close of $20.67. Day range $18.00–$20.28, opened at $20.28.
- Volume was 298.50K shares, 0.8x its 50-day average of 368.57K.
- Price is -26.0% vs its 50-day average ($25.83).
- 52-week range $13.50–$39.60; today's close sits at 22% of that range, 51.7% below the 52-week high.
Oct 12, 2026 — SCTX dips 2.4% to $20.67
- Closed at $20.67, -2.36% vs the prior close of $21.17. Day range $19.52–$22.07, opened at $21.20.
- Volume was 512.50K shares, 1.4x its 50-day average of 360.33K.
- Price is -20.1% vs its 50-day average ($25.87).
- 52-week range $13.50–$39.60; today's close sits at 27% of that range, 47.8% below the 52-week high.
Oct 9, 2026 — SCTX jumps 10.1% to $21.17, 4 up days in a row
- Closed at $21.17, +10.09% vs the prior close of $19.23. Day range $19.18–$21.33, opened at $19.21.
- Volume was 396.50K shares, 1.1x its 50-day average of 355.38K.
- Price is -18.1% vs its 50-day average ($25.85).
- 52-week range $13.50–$39.60; today's close sits at 29% of that range, 46.5% below the 52-week high.
- That makes 4 straight gains.
Oct 8, 2026 — SCTX jumps 9.4% to $19.23, 3 up days in a row
- Closed at $19.23, +9.45% vs the prior close of $17.57. Day range $16.90–$19.75, opened at $17.54.
- Volume was 351.90K shares, 1.0x its 50-day average of 354.85K.
- Price is -25.6% vs its 50-day average ($25.83).
- 52-week range $13.50–$39.60; today's close sits at 22% of that range, 51.4% below the 52-week high.
- That makes 3 straight gains.
Oct 7, 2026 — SCTX jumps 7.6% to $17.57
- Closed at $17.57, +7.59% vs the prior close of $16.33. Day range $15.75–$18.16, opened at $15.94.
- Volume was 420.50K shares, 1.2x its 50-day average of 355.01K.
- Price is -31.9% vs its 50-day average ($25.81).
- 52-week range $13.50–$39.60; today's close sits at 16% of that range, 55.6% below the 52-week high.
Oct 6, 2026 — SCTX rises 0.7% to $16.33
- Closed at $16.33, +0.74% vs the prior close of $16.21. Day range $15.37–$17.17, opened at $16.12.
- Volume was 464.40K shares, 1.3x its 50-day average of 354.10K.
- Price is -36.8% vs its 50-day average ($25.82).
- 52-week range $13.50–$39.60; today's close sits at 11% of that range, 58.8% below the 52-week high.
Oct 5, 2026 — SCTX slides 3.5% to $16.21, a 1-month low on 3.3x normal volume
- Closed at $16.21, -3.45% vs the prior close of $16.79. Day range $13.50–$17.17, opened at $17.17.
- Volume was 1.11M shares, 3.3x its 50-day average of 338.75K — unusually heavy trading.
- Price is -37.4% vs its 50-day average ($25.87).
- 52-week range $13.50–$39.60; today's close sits at 10% of that range, 59.1% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 — SCTX dips 2.3% to $16.79, a 1-month low, 3 down days in a row
- Closed at $16.79, -2.27% vs the prior close of $17.18. Day range $16.49–$17.81, opened at $17.50.
- Volume was 474.90K shares, 1.4x its 50-day average of 335.91K.
- 52-week range $16.49–$39.60; today's close sits at 1% of that range, 57.6% below the 52-week high.
- That makes 3 straight losses.
SCTX latest news & SEC filings
Every SEC filing by or about SCTX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 2, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.92M (prior year $4.90M) (-60.8% vs Jun 30, 2025)
- Net income: -$6.48M (prior year -$9.90M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$2.62 (prior year -$4.08) (loss narrowed vs Jun 30, 2025)
Sep 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 3, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Ah Equity Partners Bio Ii, L.L.C. bought 333,333 shares at $15.00 (≈$5.00M) on Jul 27, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gordon Carl L bought 1,000,000 shares at $15.00 (≈$15.00M) on Jul 27, 2026
- Gordon Carl L bought 1,000,000 shares at $15.00 (≈$15.00M) on Jul 27, 2026
- Gordon Carl L bought 1,000,000 shares at $15.00 (≈$15.00M) on Jul 27, 2026
- Gordon Carl L bought 1,000,000 shares at $15.00 (≈$15.00M) on Jul 27, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Orbimed Advisors Llc bought 1,000,000 shares at $15.00 (≈$15.00M) on Jul 27, 2026
- Orbimed Advisors Llc bought 1,000,000 shares at $15.00 (≈$15.00M) on Jul 27, 2026
- Orbimed Capital Gp Viii Llc bought 1,000,000 shares at $15.00 (≈$15.00M) on Jul 27, 2026
- Orbimed Capital Gp Viii Llc bought 1,000,000 shares at $15.00 (≈$15.00M) on Jul 27, 2026
- Orbimed Advisors Llc bought 1,000,000 shares at $15.00 (≈$15.00M) on Jul 27, 2026
- Orbimed Advisors Llc bought 1,000,000 shares at $15.00 (≈$15.00M) on Jul 27, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 29, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Avoro Ventures Llc bought 7,905 shares at $18.25 (≈$144.27K) on Jul 28, 2026
- Avoro Ventures Llc bought 7,905 shares at $18.25 (≈$144.27K) on Jul 28, 2026
- Avoro Capital Advisors Llc bought 7,905 shares at $18.25 (≈$144.27K) on Jul 28, 2026
- Avoro Capital Advisors Llc bought 7,905 shares at $18.25 (≈$144.27K) on Jul 28, 2026
- Aghazadeh Behzad bought 7,905 shares at $18.25 (≈$144.27K) on Jul 28, 2026
- Aghazadeh Behzad bought 7,905 shares at $18.25 (≈$144.27K) on Jul 28, 2026
- …plus 6 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 27, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Jul 27, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jul 27, 2026 · Form 424B4 — Final prospectus with offering price
Final prospectus with offering price
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade SCTX
- Last results release: Sep 2, 2026 (8-K Item 2.02).
- How much it moves: over the last 20 sessions the average daily move was 6.54% (largest 20.1%). That is a volatile stock.
- Liquidity: about 512.85K shares (≈$10.30M) trade per day on average.
- 52-week position: $20.08 vs a range of $13.50–$39.60 (25% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Ventures Llc Avoro bought 7,905 shares on Jul 28, 2026.
- Latest filings: 10-Q Sep 2, 2026; 8-K Sep 2, 2026; 8-K Jul 27, 2026.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
SCTX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 20.86 | 21.00 | 19.72 | 20.08 | 201.39K |
| Oct 15, 2026 | 20.79 | 21.95 | 19.73 | 20.72 | 180.90K |
| Oct 14, 2026 | 18.81 | 21.99 | 18.81 | 20.77 | 391.30K |
| Oct 13, 2026 | 20.28 | 20.28 | 18.00 | 19.12 | 298.50K |
| Oct 12, 2026 | 21.20 | 22.07 | 19.52 | 20.67 | 512.50K |
| Oct 9, 2026 | 19.21 | 21.33 | 19.18 | 21.17 | 396.50K |
| Oct 8, 2026 | 17.54 | 19.75 | 16.90 | 19.23 | 351.90K |
| Oct 7, 2026 | 15.94 | 18.16 | 15.75 | 17.57 | 420.50K |
| Oct 6, 2026 | 16.12 | 17.17 | 15.37 | 16.33 | 464.40K |
| Oct 5, 2026 | 17.17 | 17.17 | 13.50 | 16.21 | 1.11M |
| Oct 2, 2026 | 17.50 | 17.81 | 16.49 | 16.79 | 474.90K |
| Oct 1, 2026 | 18.41 | 19.36 | 17.00 | 17.18 | 669.20K |
| Sep 30, 2026 | 23.03 | 23.40 | 17.70 | 18.41 | 1.18M |
| Sep 29, 2026 | 21.53 | 23.75 | 21.29 | 23.03 | 671.20K |
| Sep 28, 2026 | 21.28 | 22.00 | 20.50 | 21.77 | 306.90K |
| Sep 25, 2026 | 23.17 | 23.28 | 20.21 | 21.28 | 458.50K |
| Sep 24, 2026 | 26.27 | 26.27 | 21.36 | 21.61 | 525.50K |
| Sep 23, 2026 | 28.51 | 29.09 | 26.08 | 26.53 | 532.70K |
| Sep 22, 2026 | 28.52 | 30.36 | 25.00 | 28.07 | 584.50K |
| Sep 21, 2026 | 32.88 | 34.49 | 27.32 | 28.05 | 528.60K |
About Scribe Therapeutics
Scribe Therapeutics (SCTX) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in ALAMEDA, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1853921.
SCTX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Behzad Aghazadeh | See Remarks | Jul 28, 2026 |
| Capital Advisors Llc Avoro | See Remarks | Jul 28, 2026 |
| Ventures Llc Avoro | See Remarks | Jul 28, 2026 |
| Joshua Bleharski | Director | Jul 27, 2026 |
| Carl L Gordon | Director | Jul 29, 2026 |
| Advisors Llc Orbimed | Director | Jul 29, 2026 |
| Benjamin L. Oakes | President, CEO | Jul 27, 2026 |
| Capital Gp Viii Llc Orbimed | Director | Jul 29, 2026 |
| James Dean Watson | Director | Jul 27, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Svetlana Lucas | Chief Business Officer | Jul 27, 2026 |
| Benjamin L. Oakes | President, CEO | Jul 27, 2026 |
| David Parrot | Chief Financial Officer | Jul 27, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 28, 2026 | Ventures Llc Avoro | Buy | 7,905 | $18.25 |
| Jul 28, 2026 | Ventures Llc Avoro | Buy | 7,905 | $18.25 |
| Jul 28, 2026 | Capital Advisors Llc Avoro | Buy | 7,905 | $18.25 |
| Jul 28, 2026 | Capital Advisors Llc Avoro | Buy | 7,905 | $18.25 |
| Jul 28, 2026 | Behzad Aghazadeh | Buy | 7,905 | $18.25 |
| Jul 28, 2026 | Behzad Aghazadeh | Buy | 7,905 | $18.25 |
| Jul 28, 2026 | Ventures Llc Avoro | Buy | 7,905 | $18.25 |
| Jul 28, 2026 | Ventures Llc Avoro | Buy | 7,905 | $18.25 |
| Jul 28, 2026 | Capital Advisors Llc Avoro | Buy | 7,905 | $18.25 |
| Jul 28, 2026 | Capital Advisors Llc Avoro | Buy | 7,905 | $18.25 |
| Jul 28, 2026 | Behzad Aghazadeh | Buy | 7,905 | $18.25 |
| Jul 28, 2026 | Behzad Aghazadeh | Buy | 7,905 | $18.25 |
| Jul 27, 2026 | Advisors Llc Orbimed | Buy | 1,000,000 | $15.00 |
| Jul 27, 2026 | Advisors Llc Orbimed | Buy | 1,000,000 | $15.00 |
| Jul 27, 2026 | Capital Gp Viii Llc Orbimed | Buy | 1,000,000 | $15.00 |
SCTX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $57.93M, total liabilities $102.42M, cash $35.59M (as of Jun 30, 2026).
SCTX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Sep 2, 2026 | 8-K Item 2.02 (results) | $30.90 |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on SCTX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.